Oral Abstract Session: Parallel Session 10: Bioengineering and therapeutics
Friday October 24, 2025 from 08:30 to 10:00
Hall A2-3
Moderator
Lectures
  • 08:30 - 08:50
    PS10.1 Development of clinical application guidance for extracellular vesicles and future perspectives including the JSRM-ISEV MOU: Toward international collaboration and industrialization
    Prof. Shuji Terai, Japan
  • 08:50 - 09:02
    PS10.2 PEGylated-biomimetic nanoparticles for enhanced treatment of idiopathic pulmonary fibrosis
    Miss Jisu Son, Korea
  • 09:02 - 09:14
    PS10.3 Breakthroughs in 3D printing, functional human islets in an alginate-dECM bioink
    Giuseppe Orlando, United States
  • 09:14 - 09:26
    PS10.4 Oxygen enabled, high capacity, open encapsulation devices implanted subcutaneously vascularized and reversed diabetes in immunodeficient rats
    Amy Kelly, United States
  • 09:26 - 09:38
    PS10.5 Targeted lung drug delivery via single-cell particle conjugation for asthma treatment
    Miss Ji H Cho, Korea
  • 09:38 - 09:50
    PS10.6 Progesterone-induced hybrid epithelial/mesenchymal states enhance regenerative and immunomodulatory properties of amniotic epithelial cells
    Dr. Angelo Canciello, Italy

© 2025 CTRMS 2025